Four Startups provides entrepreneurship support services in collaboration with Japan's top-ranked venture capitalists. In this service, our human capitalists search for outstanding human resources who have the courage and leadership to take on the challenge of solving social issues, brush up business plans with Japan's leading venture capitalists, and create startup companies and entrepreneurs with investments of several hundred million yen. The program is an initiative to create startup companies and entrepreneurs with investments of several hundred million yen.
(CEO: Takayuki Hoshino), GRAPHER Corporation (CEO: Daichi Ishii), TERASS Corporation (CEO: Ryosuke Eguchi), and Blue Practice Corporation (President: Koji Suzuki). This is the fifth company to receive this support.
About Yuimedi
Yuimedi is a company that unites the sincere desire to cure and the earnest wish to be cured through medical and healthcare system data. The company develops products and provides consultation based on the keywords of medical care x data x joint decision-making with patients. Supporting the implementation of medical real-world data research and evidence-based medicine (EBM).
Profile of Mr. Emiri Grimes, President and Representative Director, Yuimedi Inc.
After graduating from Kyoto University, Faculty of Pharmacy and obtaining his pharmacist license, he joined Takeda Pharmaceutical Company Limited. After working in clinical trial management in the development department, he became interested in improving the Japanese healthcare system through industry, government, and academia, and obtained a Master of Medical Industry and Pharmacy from ETH Zurich, Switzerland. He then worked as a management consultant at McKinsey & Company and founded Yuimedi Inc. in 2020.
The story of how he started his business is introduced in our ondemand media "EVANGE".
EVANGE URL :. https://evange.jp/n/n3cabf0ac427c
Mr. Yusuke Murata, Managing Partner, Incubate Fund Corporation Comments
Around the end of 2019, President Shimizu introduced us to Grimes, and after a little over half a year of discussions, we were able to establish Yuimedi with this team/seat group. Although the industry has only just begun to utilize medical big data to improve the quality of medical care, we see this as an area that is in urgent need of social implementation now that social issues related to medical care have been highlighted by the spread of the new coronavirus infection. I am looking forward to accompanying you and the wonderful team led by Mr. Grimes and supporting you in this great challenge.
Comment from Mr. Yuichiro Shimizu, Representative Director and CEO, Four Startups, Inc.
Since our company's inception, we have shared and discussed a group of themes of social issues to be solved with our incubate funders, and have supported their entrepreneurial challenges by identifying individuals who have the potential to solve such issues. Grimes had a clear awareness of the current situation in Japan and the issues in the healthcare sector, so we immediately engaged Representative Partner Murata, who is working to solve social issues in the healthcare sector as one of our investment areas. We will continue to support Mr. Grimes' challenge and work with everyone involved in the startup ecosystem to build a society where it is natural for people from various backgrounds to challenge their own potential.
We will continue to support the growth of entrepreneurs and startup companies to develop the startup ecosystem that is important for Japan's growth.
Outline of Yuimedi Corporation
| name of company | Yuimedi Corporation |
| Establishment | November 30, 2020 |
| capital stock | Ark Mori Building 3F, 1-12-32 Akasaka, Minato-ku, Tokyo |
| representative | President and Representative Director Grimes, Emiri |
| Business Overview | 1. acquisition of medical data and construction of database 2. medical data analysis, research and consulting services (3) Contracted analysis using various types of information and related consulting services 4. planning, development and operation of matching services for epidemiological research 5. epidemiological studies, preparation and marketing of papers and reports |
| uniform resouce locator | https://yuimedi.com/ |
Overview of Four Startups, Inc.
Four Startups is a company that supports the growth of Japan by creating industries, companies, services, and people that can compete on the global stage. The company is promoting growth industry support business centered on startup support and job transfer support, including the Internet/IoT sector and real business domains such as deep tech. The company also provides strategic financial support to startups and venture companies in collaboration with Japan's leading venture capital firms, operates the "STARTUP DB," an information platform specializing in growth industries, and works to strengthen the industrial ecosystem through a business co-creation model with large companies. The company will also work to strengthen the industrial ecosystem through a business co-creation model with large companies.
| name of company | Four Start Ups, Inc. |
| Establishment | September 1, 2016 |
| capital stock | Izumi Garden Tower 36F, 1-6-1 Roppongi, Minato-ku, Tokyo |
| representative | Representative Director, President and CEO Yuichiro Shimizu |
| Business Overview | Growth Industry Support Business |
| uniform resouce locator | https://forstartups.com/ |






